What are the risk factors for placenta accreta spectrum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for Placenta Accreta Spectrum

The most critical risk factor for placenta accreta spectrum is prior cesarean delivery combined with placenta previa, creating a dramatically escalating risk from 3% with no prior cesarean to 67% with five or more prior cesareans. 1, 2

Primary Risk Factors

Prior Cesarean Delivery

  • Previous cesarean delivery is the single most common and important modifiable risk factor, with risk increasing in a dose-dependent manner with each additional cesarean 1, 2
  • In women without placenta previa: risk increases from 0.3% with one prior cesarean to 6.74% with five or more cesareans 1, 2
  • The rising incidence of placenta accreta spectrum over the past four decades (from 1 in 2,510 to 1 in 272 deliveries) directly parallels the increased cesarean delivery rate 1, 2

Placenta Previa: The Critical Multiplier

  • Placenta previa is present in more than 80% of placenta accreta spectrum cases, making it the most important ultrasonographic association 1
  • When placenta previa occurs without prior cesarean: 3% risk of accreta spectrum 1, 2
  • When placenta previa overlies a cesarean scar, risk escalates dramatically 1, 2:
    • One prior cesarean: 11%
    • Two prior cesareans: 40%
    • Three prior cesareans: 61%
    • Five or more prior cesareans: 67%
  • Placenta previa overlying a cesarean scar is present in 49% of all accreta spectrum cases 2

Additional Established Risk Factors

Other Uterine Surgery and Instrumentation

  • Prior uterine surgeries including myomectomy with endometrial cavity entry significantly increase risk 1, 2, 3, 4
  • Prior curettage procedures (dilation and curettage) are independently associated with placenta accreta spectrum (OR 2.8) 1, 2, 5
  • Hysteroscopic surgery carries substantial risk (OR 5.7) 5
  • Uterine artery embolization has the highest odds ratio among surgical interventions (OR 44.1) 5
  • Asherman syndrome (intrauterine adhesions) is an established risk factor 1, 2

Maternal Characteristics

  • Advanced maternal age (≥35 years) is an independent risk factor 1, 2, 6
  • Multiparity increases risk 1
  • BMI ≥30 is independently associated with placenta accreta spectrum in high-risk populations 7

Pregnancy-Related Factors

  • In vitro fertilization and assisted reproductive technology increase risk (OR 4.1) 2, 5
  • Prior postpartum hemorrhage is associated with increased risk 7
  • Short interpregnancy interval (<18 months after cesarean) increases risk (OR 6.3) in women with single prior cesarean 4
  • Smoking is associated with increased risk (OR 5.8) in women with single prior cesarean 4

Pathophysiology Context

The underlying mechanism involves defects in the endometrial-myometrial interface leading to failure of normal decidualization in areas of uterine scarring, which allows abnormally deep placental anchoring villi and trophoblast infiltration 1, 3, 8. This explains why any disruption within the uterine cavity that damages this interface—whether from cesarean delivery, curettage, or myomectomy entering the endometrial cavity—increases the likelihood of placenta accreta 1, 3.

Critical Clinical Pitfalls to Avoid

  • Do not rely solely on ultrasound findings: clinical risk factors remain equally important as predictors even when ultrasound appears normal 1, 8
  • Recognize the exponential risk with combined factors: a woman with two prior cesareans and anterior placenta previa has a 40% risk—this is not a low-risk scenario 1, 2
  • Posterior low-lying placenta carries lower risk (5% with one prior cesarean) compared to anterior placenta previa, allowing for risk stratification 7
  • Early identification is critical: approximately 50% of women with accreta spectrum who wait beyond 36 weeks require emergent delivery for hemorrhage 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Incidence and Risk Factors of Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical Risk Factors for Placenta Accreta or Placenta Percreta: A Case-Control Study.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2024

Research

Clinical risk factors for placenta previa-placenta accreta.

American journal of obstetrics and gynecology, 1997

Related Questions

How do I diagnose placenta accreta spectrum in a pregnant woman in the second or third trimester with risk factors such as prior cesarean delivery, uterine surgery, or placenta previa?
What are the management options for a patient with a history of three cesarean sections (C-sections)?
What is the incidence of placenta accreta syndrome among primigravid (first-time pregnant) women in a specific location?
What is the recommended management approach for Placenta Accreta?
In a pregnant woman with risk factors such as prior cesarean delivery, placenta previa, previous uterine surgery, or advanced maternal age, how should placenta accreta spectrum be diagnosed and managed, including recommended imaging, timing of delivery, surgical approach, and intra‑operative measures to control hemorrhage?
What is the appropriate evaluation and management for a patient presenting with neck pain and a cervical cyst?
What is the recommended dosing schedule for 0.3% ciprofloxacin ophthalmic solution in adults and children, including duration, frequency, and special considerations such as contact lens wear and contraindications?
How should a febrile newborn (≤28 days old) be evaluated and managed?
How do I take a comprehensive patient history using the OPQRST (Onset, Provocation/Palliation, Quality, Radiation, Severity, Timing) framework and a systematic review of systems?
How should hypotension be managed in a patient with dilated cardiomyopathy and reduced ejection fraction?
In a healthy 30‑year‑old woman with frequent spontaneous bruising, what is the recommended von Willebrand factor testing panel and subsequent platelet function testing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.